back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2020-11-23 14:30 Tx date 2020-11-19 |
$PRMO
Primo Nutraceuticals Inc. |
Jagpal, Amandip
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-5,400
-60,000 vol $0.09 each |
3,598,146 | |
| Filed 2020-11-20 13:41 Tx date 2020-11-20 |
$PRMO
Primo Nutraceuticals Inc. |
Singh, Teja
4 - Director of Issuer
Direct Ownership
|
Common Shares
99 - Correction of information
|
+213,333 vol |
1,723,333 | |
| Filed 2020-10-27 15:06 Tx date 2020-10-27 |
$PRMO
Primo Nutraceuticals Inc. |
DeBellefeuille, Joel
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$480.00
+4,000 vol $0.12 each |
487,399 | |
| Filed 2020-10-15 17:23 Tx date 2020-10-08 |
$PRMO
Primo Nutraceuticals Inc. |
DeBellefeuille, Joel
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,443
-11,100 vol $0.13 each |
133,399 | |
| Filed 2020-10-15 17:19 Tx date 2020-10-15 |
$PRMO
Primo Nutraceuticals Inc. |
Cindric, Richard
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: 1028104 BC Ltd. (Indirect Ownership)
|
Common Shares
46 - Compensation for services
|
$30,000
+250,000 vol $0.12 each |
650,000 | |
| Filed 2020-10-15 17:19 Tx date 2017-07-02 |
$PRMO
Primo Nutraceuticals Inc. |
Cindric, Richard
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: 1028104 BC Ltd. (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
400,000 | ||
| Filed 2020-10-15 17:18 Tx date 2020-10-15 |
$PRMO
Primo Nutraceuticals Inc. |
Cindric, Richard
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
99 - Correction of information
|
$129,010
+1,720,145 vol $0.075 each |
2,773,411 | |
| Filed 2020-10-15 17:13 Tx date 2020-10-15 |
$PRMO
Primo Nutraceuticals Inc. |
Singh, Teja
4 - Director of Issuer
Direct Ownership
|
Common Shares
46 - Compensation for services
|
$18,000
+150,000 vol $0.12 each |
1,510,000 | |
| Filed 2020-10-15 17:12 Tx date 2020-10-15 |
$PRMO
Primo Nutraceuticals Inc. |
Jagpal, Amandip
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
46 - Compensation for services
|
$30,000
+250,000 vol $0.12 each |
3,658,146 | |
| Filed 2020-10-15 17:08 Tx date 2020-10-15 |
$PRMO
Primo Nutraceuticals Inc. |
DeBellefeuille, Joel
4 - Director of Issuer
Direct Ownership
|
Common Shares
46 - Compensation for services
|
$12,000
+100,000 vol $0.12 each |
483,399 | |
| Filed 2020-10-15 17:05 Tx date 2020-10-15 |
$PRMO
Primo Nutraceuticals Inc. |
DeBellefeuille, Joel
4 - Director of Issuer
Direct Ownership
|
Common Shares
46 - Compensation for services
|
$30,000
+250,000 vol $0.12 each |
383,399 | |
| Filed 2020-09-18 18:48 Tx date 2020-09-09 |
$PRMO
Primo Nutraceuticals Inc. |
Bechtel, Mark William
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
666,666 | ||
| Filed 2020-09-14 19:13 Tx date 2020-09-10 |
$PRMO
Primo Nutraceuticals Inc. |
DeBellefeuille, Joel
4 - Director of Issuer
Direct Ownership
|
Common Shares
46 - Compensation for services
|
$9,999
+133,333 vol $0.075 each |
144,499 | |
| Filed 2020-09-14 15:18 Tx date 2020-09-14 |
$PRMO
Primo Nutraceuticals Inc. |
Jagpal, Amandip
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
46 - Compensation for services
|
$208,364
+2,778,191 vol $0.075 each |
3,408,146 | |
| Filed 2020-09-14 15:18 Tx date 2020-09-14 |
$PRMO
Primo Nutraceuticals Inc. |
Jagpal, Amandip
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
47 - Acquisition or disposition by gift
|
-50,000 vol |
629,955 | |
| Filed 2020-09-14 15:17 Tx date 2020-09-14 |
$PRMO
Primo Nutraceuticals Inc. |
Jagpal, Amandip
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-9,519,378 vol |
679,955 | |
| Filed 2020-09-14 15:15 Tx date 2020-09-14 |
$PRMO
Primo Nutraceuticals Inc. |
Jagpal, Amandip
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
99 - Correction of information
|
-5,777,000 vol |
10,199,333 | |
| Filed 2020-09-11 17:47 Tx date 2020-08-26 |
$PRMO
Primo Nutraceuticals Inc. |
Cindric, Richard
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-14,725,734 vol |
1,053,266 | |
| Filed 2020-09-11 16:16 Tx date 2020-09-01 |
$PRMO
Primo Nutraceuticals Inc. |
DeBellefeuille, Joel
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
+2,500 vol |
11,166 | |
| Filed 2020-09-11 16:16 Tx date 2020-08-26 |
$PRMO
Primo Nutraceuticals Inc. |
DeBellefeuille, Joel
4 - Director of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-121,334 vol |
8,666 | |
| Filed 2020-09-11 16:14 Tx date 2020-07-23 |
$PRMO
Primo Nutraceuticals Inc. |
DeBellefeuille, Joel
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
-115,000 vol |
400,000 | |
| Filed 2020-09-11 16:14 Tx date 2020-09-01 |
$PRMO
Primo Nutraceuticals Inc. |
DeBellefeuille, Joel
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$387.50
+2,500 vol $0.155 each |
||
| Filed 2020-09-11 16:13 Tx date 2020-08-26 |
$PRMO
Primo Nutraceuticals Inc. |
DeBellefeuille, Joel
4 - Director of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-228,667 vol |
||
| Filed 2020-09-11 14:08 Tx date 2020-09-01 |
$PRMO
Primo Nutraceuticals Inc. |
DeBellefeuille, Joel
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$387.50
+2,500 vol $0.155 each |
18,833 | |
| Filed 2020-09-11 14:08 Tx date 2020-09-01 |
$PRMO
Primo Nutraceuticals Inc. |
DeBellefeuille, Joel
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$387.50
+2,500 vol $0.155 each |
||
| Filed 2020-09-11 14:08 Tx date 2020-08-26 |
$PRMO
Primo Nutraceuticals Inc. |
DeBellefeuille, Joel
4 - Director of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-228,667 vol |
16,333 | |
| Filed 2020-09-11 14:08 Tx date 2020-08-26 |
$PRMO
Primo Nutraceuticals Inc. |
DeBellefeuille, Joel
4 - Director of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-228,667 vol |
||
| Filed 2020-09-11 14:05 Tx date 2020-09-01 |
$PRMO
Primo Nutraceuticals Inc. |
DeBellefeuille, Joel
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$387.50
+2,500 vol $0.155 each |
||
| Filed 2020-09-11 13:57 Tx date 2020-09-01 |
$PRMO
Primo Nutraceuticals Inc. |
DeBellefeuille, Joel
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$387.50
+2,500 vol $0.155 each |
247,500 | |
| Filed 2020-09-11 13:57 Tx date 2020-09-01 |
$PRMO
Primo Nutraceuticals Inc. |
DeBellefeuille, Joel
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$387.50
+2,500 vol $0.155 each |
||
| Filed 2020-09-11 13:53 Tx date 2020-09-01 |
$PRMO
Primo Nutraceuticals Inc. |
DeBellefeuille, Joel
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$310.00
+2,000 vol $0.155 each |
||
| Filed 2020-09-11 13:53 Tx date 2020-09-01 |
$PRMO
Primo Nutraceuticals Inc. |
DeBellefeuille, Joel
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$310.00
+2,000 vol $0.155 each |
||
| Filed 2020-09-11 13:52 Tx date 2020-08-20 |
$PRMO
Primo Nutraceuticals Inc. |
DeBellefeuille, Joel
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,200
-120,000 vol $0.01 each |
245,000 | |
| Filed 2020-09-11 13:52 Tx date 2020-08-04 |
$PRMO
Primo Nutraceuticals Inc. |
DeBellefeuille, Joel
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,500
-150,000 vol $0.01 each |
365,000 | |
| Filed 2020-08-17 15:55 Tx date 2020-03-30 |
$PRMO
Primo Nutraceuticals Inc. |
Cindric, Richard
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-7,000
-700,000 vol $0.01 each |
20,120,000 | |
| Filed 2020-08-17 15:54 Tx date 2020-04-02 |
$PRMO
Primo Nutraceuticals Inc. |
Cindric, Richard
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-180.00
-12,000 vol $0.015 each |
20,108,000 | |
| Filed 2020-08-17 15:54 Tx date 2020-04-06 |
$PRMO
Primo Nutraceuticals Inc. |
Cindric, Richard
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-5,000
-500,000 vol $0.01 each |
19,608,000 | |
| Filed 2020-08-17 15:52 Tx date 2020-06-10 |
$PRMO
Primo Nutraceuticals Inc. |
Cindric, Richard
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-22,500
-1,500,000 vol $0.015 each |
17,079,000 | |
| Filed 2020-08-17 15:51 Tx date 2020-06-11 |
$PRMO
Primo Nutraceuticals Inc. |
Cindric, Richard
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-19,500
-1,300,000 vol $0.015 each |
15,779,000 | |
| Filed 2020-08-17 15:50 Tx date 2020-06-11 |
$PRMO
Primo Nutraceuticals Inc. |
Cindric, Richard
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-2,115
-141,000 vol $0.015 each |
||
| Filed 2020-08-17 15:50 Tx date 2020-06-11 |
$PRMO
Primo Nutraceuticals Inc. |
Cindric, Richard
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-17,385
-1,159,000 vol $0.015 each |
||
| Filed 2020-08-17 15:48 Tx date 2020-06-11 |
$PRMO
Primo Nutraceuticals Inc. |
Cindric, Richard
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-2,115
-141,000 vol $0.015 each |
||
| Filed 2020-08-17 15:48 Tx date 2020-06-11 |
$PRMO
Primo Nutraceuticals Inc. |
Cindric, Richard
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-17,385
-1,159,000 vol $0.015 each |
||
| Filed 2020-07-17 15:46 Tx date 2020-07-15 |
$PRMO
Primo Nutraceuticals Inc. |
DeBellefeuille, Joel
4 - Director of Issuer
Direct Ownership
|
Common Shares
46 - Compensation for services
|
$6,750
+450,000 vol $0.015 each |
515,000 | |
| Filed 2020-07-17 15:44 Tx date 2020-06-11 |
$PRMO
Primo Nutraceuticals Inc. |
DeBellefeuille, Joel
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,275
-85,000 vol $0.015 each |
65,000 | |
| Filed 2020-06-08 15:56 Tx date 2020-06-05 |
$PRMO
Primo Nutraceuticals Inc. |
Cindric, Richard
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-15,435
-1,029,000 vol $0.015 each |
19,791,000 | |
| Filed 2020-06-04 23:18 Tx date 2020-06-03 |
$PRMO
Primo Nutraceuticals Inc. |
DeBellefeuille, Joel
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$550.00
+22,000 vol $0.025 each |
150,000 | |
| Filed 2020-06-04 23:17 Tx date 2020-05-27 |
$PRMO
Primo Nutraceuticals Inc. |
DeBellefeuille, Joel
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-2,850
-190,000 vol $0.015 each |
128,000 | |
| Filed 2020-05-21 15:41 Tx date 2020-05-13 |
$PRMO
Primo Nutraceuticals Inc. |
DeBellefeuille, Joel
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-480.00
-32,000 vol $0.015 each |
318,000 | |
| Filed 2020-05-01 15:26 Tx date 2020-05-01 |
$PRMO
Primo Nutraceuticals Inc. |
DeBellefeuille, Joel
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$600.00
+40,000 vol $0.015 each |
350,000 | |
| Filed 2020-04-14 17:32 Tx date 2020-04-09 |
$PRMO
Primo Nutraceuticals Inc. |
DeBellefeuille, Joel
4 - Director of Issuer
Direct Ownership
|
Common Shares
46 - Compensation for services
|
$3,750
+250,000 vol $0.015 each |
310,000 | |
| Filed 2020-04-09 17:27 Tx date 2020-04-06 |
$PRMO
Primo Nutraceuticals Inc. |
GORDON, DONALD
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$-52,000
-2,600,000 vol $0.02 each |
536,433 | |
| Filed 2020-04-06 16:30 Tx date 2020-04-06 |
$PRMO
Primo Nutraceuticals Inc. |
GORDON, DONALD
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$52,000
+2,600,000 vol $0.02 each |
||
| Filed 2020-04-08 18:44 Tx date 2020-04-07 |
$PRMO
Primo Nutraceuticals Inc. |
DeBellefeuille, Joel
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
60,000 | ||
| Filed 2020-04-06 16:30 Tx date 2020-04-06 |
$PRMO
Primo Nutraceuticals Inc. |
GORDON, DONALD
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$52,000
+2,600,000 vol $0.02 each |
5,736,433 | |
| Filed 2020-03-17 14:03 Tx date 2020-03-13 |
$PRMO
Primo Nutraceuticals Inc. |
Singh, Teja
4 - Director of Issuer
Direct Ownership
|
Common Shares
46 - Compensation for services
|
$96,000
+6,400,000 vol $0.015 each |
||
| Filed 2020-03-16 16:30 Tx date 2020-03-13 |
$PRMO
Primo Nutraceuticals Inc. |
Singh, Teja
4 - Director of Issuer
Direct Ownership
|
Common Shares
46 - Compensation for services
|
$96,000
+6,400,000 vol $0.015 each |
||
| Filed 2020-03-16 16:30 Tx date 2020-03-13 |
$PRMO
Primo Nutraceuticals Inc. |
Singh, Teja
4 - Director of Issuer
Direct Ownership
|
Common Shares
46 - Compensation for services
|
$96,000
+6,400,000 vol $0.015 each |
6,400,000 | |
| Filed 2020-03-16 16:27 Tx date 2017-08-26 |
$PRMO
Primo Nutraceuticals Inc. |
Singh, Teja
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-11-26 13:37 Tx date 2019-11-26 |
$PRMO
Primo Nutraceuticals Inc. |
Jagpal, Amandip
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-8,000
-400,000 vol $0.02 each |
15,976,333 | |
| Filed 2019-11-26 13:37 Tx date 2019-11-19 |
$PRMO
Primo Nutraceuticals Inc. |
Jagpal, Amandip
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-11,841.675
-473,667 vol $0.025 each |
16,376,333 | |
| Filed 2019-11-26 13:36 Tx date 2019-11-13 |
$PRMO
Primo Nutraceuticals Inc. |
Jagpal, Amandip
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-10,000
-400,000 vol $0.025 each |
16,850,000 | |
| Filed 2019-11-04 16:48 Tx date 2019-11-04 |
$PRMO
Primo Nutraceuticals Inc. |
Jagpal, Amandip
4 - Director of Issuer
Direct Ownership
|
Common Shares
99 - Correction of information
|
+2,250,000 vol |
17,250,000 | |
| Filed 2019-11-04 14:12 Tx date 2019-11-04 |
$PRMO
Primo Nutraceuticals Inc. |
Cindric, Richard
4 - Director of Issuer
Direct Ownership
|
Common Shares
99 - Correction of information
|
+6,720,000 vol |
20,820,000 |